Washington Institute for Coagulation

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Haemophilia6 trials

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Completed4 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Pfizer4 trials
• CSL Behring1 trial
• Hoffmann-La Roche1 trial

Running trials

• Recruiting

  Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  NCT05568719· Phase 3· Pfizer· Source

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

  NCT04370054· Phase 3· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Haemophilia1 recruiting

Closed trials

• Completed

  Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

  NCT03938792· Phase 3· Pfizer· Source

• Completed

  A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

  NCT04158648· Phase 3· Hoffmann-La Roche· Source

• Completed

  HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

  NCT03569891· Phase 3· CSL Behring· Source

• Completed

  A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

  NCT03061201· Phase 2· Pfizer· Source